Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological
Sponsor: SunWay Biotech Co., LTD.
Summary
This open-label, single-group, pre/post-test clinical study was conducted to investigate whether ExoBDNF probiotic supplementation could improve cognitive ability. It is expected that 40 subjects aged 18 years and above will be recruited, with a target of 30 cases, to take ExoBDNF probiotics for a total of 8 weeks.
Official title: Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological Outcomes: An Open-label Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-05-20
Completion Date
2025-12-30
Last Updated
2025-11-24
Healthy Volunteers
Yes
Interventions
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Product ingredients: microcrystalline cellulose, corn starch, SWP-CGPA01 Pediococcus acidilactici powder (1.0 x 10\^10 CFU); Capsule shell composition: HPMC (hydroxypropyl methylcellulose), pure water, titanium dioxide, gelatin.
Locations (1)
Tri-Service General Hospital, National Defense Medical Center
Taipei, Taiwan